Location History:
- Brooklhne, MA (US) (1993)
- Brookline, MA (US) (1997 - 2015)
Company Filing History:
8 out of 8 
3 out of 15 
1 out of 1 Years Active: 1993-2015
Title: Theoharis C. Theoharides: Innovator in Autism Spectrum Disorder Research
Introduction
Theoharis C. Theoharides, based in Brookline, MA, is a prominent researcher and inventor with a prolific portfolio of 20 patents. His work primarily focuses on developing innovative methods and compositions aimed at addressing autism spectrum disorders (ASD). Through his contributions, he seeks to bring new therapeutic approaches to this challenging field.
Latest Patents
Among his most notable recent patents are:
1. **Methods of treating autism spectrum disorders and compositions for same** - This patent discloses compositions that target brain blood vessel leakage and explores various methods for treating ASD. It also provides innovative techniques for screening individuals for autism spectrum disorders.
2. **Methods of screening for and treating autism spectrum disorders and compositions for same** - This invention details methods designed for screening autism spectrum disorders and includes compositions that prevent the release of molecules harmful to the blood-brain barrier. It emphasizes the treatment avenues available for managing ASD.
Career Highlights
Theoharides has had an influential career, exemplified by his numerous patents and research contributions. His innovative approaches in the healthcare sector have advanced the understanding and treatment of autism, showing his commitment to improving the quality of life for individuals affected by these disorders.
Collaborations
Throughout his career, Theoharides has worked with various organizations, including Theta Biomedical Consulting & Development Co., Inc. His collaborations with different entities reflect a dedication to merging research and practical applications in medical science.
Conclusion
Theoharis C. Theoharides stands out as a significant figure in the innovative research surrounding autism spectrum disorders. With a robust patent portfolio and impactful collaborations, his work continues to pave the way for new therapeutic strategies, promising advancements for individuals diagnosed with ASD. His contributions not only enhance scientific knowledge but also provide hope for improved treatment options in the future.